Home   >  
Plerixafor
      >   Publication

    Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo

    Yi Chen, Jing Li, and David Oupicky
    Bioconjug Chem. 2018 Feb 21; 29(2): 296–305.

    Abstract This study reports on a simple method to prepare siRNA-polycation conjugate polyplexes by in situ thiol–disulfide exchange reaction. The conjugate polyplexes are prepared using thiol-terminated siRNA and a bioreducible branched polycationic inhibitor of the CXCR4 chemokine receptor (rPAMD). The rPAMD-SS-siRNA conjugate polyplexes exhibit improved colloidal stability and resistance against disassembly with heparin, serum, and physiological salt concentrations when compared with control conventional rPAMD/siRNA polyplexes. Coating the polyplexes with human serum albumin masks the positive surface charge and contributes to the enhanced in vitro gene silencing and improved safety in vivo. The conjugate polyplexes display improved in vivo reporter gene silencing following intravenous injection in tumor-bearing mice. Because the conjugate polyplexes retained the ability of rPAMD to inhibit CXCR4 and restrict cancer cell invasion, the developed systems show promise for future combination anti-metastatic siRNA therapies of cancer.

    0086-13720134139
    日本毛多水大免费视频_男人的天堂视频在线观看免费_国产区精品综合在线